LEXICON
No.153 August 17, 2016

Sakigake Designation Scheme
先駆け審査指定制度

Japan introduced the “ sakigake ” designation scheme (先駆け審査指定制度; sakigake shinsa shitei seido ) on a pilot basis in 2015, aiming to accelerate the time to market for innovative drug candidates by giving them a series of privileges in both...

To read the full story

LEXICON

Takeda Pharmaceutical CEO Christophe Weber highlighted the importance of gaining a strong foothold in the world’s largest pharma market at…

By Reiji Anasako

While generic drugs post solid growth in volume-based shares in Japan, their makers are pondering ways to retool their business…

By Yoshinori Sagehashi

Daiichi Sankyo and GlaxoSmithKline recently announced that they have agreed to dissolve their joint venture company, Japan Vaccine. The failure of this model of joint venture between a major Japanese and foreign drug maker in just six years is disappointing.Over…

By Gregory Ng

To many people, Japan has always been one of the world’s most advanced economies and a market of rich opportunities with one of the top healthcare systems worldwide.Add a rapidly changing demographic, a declining workforce, and the constant challenges of…